The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
Status:
Recruiting
Trial end date:
2022-08-15
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo controlled trial to evaluate the
effect and safety of Liraglutide Injection on body weight loss compared with placebo in obese
or overweight adult patients with comorbidity of metabolic disorders.